Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg

• Status: Terminated
• Trial end date: 2008-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effectiveness and safety of rosuvastatin 5mg in lowering blood cholesterol, compared to one other medicine, atorvastatin 10mg in Asian patients in the UK.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Atorvastatin; Atorvastatin Calcium; Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Self described Asian, first or second generation

• Male or female > or = 18 years with primary hypercholesterolaemia.

Exclusion Criteria:

• Use of cholesterol lowering drugs from visit 1

• Homozygous familial hypercholesterolaemia

• Active arterial disease within 3 months of study entry

• Poorly controlled diabetes

• Uncontrolled hypothyroidism

• Active liver disease

• History of alcoh/drug abuse.